Exhibit 10.1

 

ONCONOVA THERAPEUTICS, INC.

CONTROLLED EQUITY OFFERINGSM

 

TERMINATION OF

SALES AGREEMENT

 

January 5, 2016

 

Cantor Fitzgerald & Co.

499 Park Avenue

New York, NY 10022

 

Ladies and Gentlemen:

 

Reference is made to the Sales Agreement, dated October 8, 2014, including the
Schedules thereto, between Cantor Fitzgerald & Co. (“CF&Co”) and Onconova
Therapeutics, Inc., a Delaware corporation (the “Company”), as amended by
Amendment No. 1 to Sales Agreement, dated September 30, 2015 (the “Sales
Agreement”), pursuant to which the Company agreed to sell through CF&Co, as
sales agent, shares of common stock, par value $0.01 per share, of the Company. 
All capitalized terms used and not otherwise defined herein shall have the
respective meanings assigned to such terms in the Sales Agreement.  CF&Co and
the Company agree as follows:

 

A.            Termination of Sales Agreement.  Pursuant to Section 13(d) of the
Sales Agreement, the Company and Cantor hereby mutually agree to terminate the
Sales Agreement, effective as of the date hereof.

 

B.            Counterparts.  This Termination of Sales Agreement may be executed
in two or more counterparts, each of which shall be deemed an original, but all
of which together shall constitute one and the same instrument.  Delivery by one
party to the other may be made by facsimile or email transmission.

 

C.            Governing Law.  This Termination of Sales Agreement shall be
governed by, and construed in accordance with, the internal laws of the State of
New York without regard to the principles of conflicts of laws.

 

[Remainder of page intentionally left blank.]

 

--------------------------------------------------------------------------------

 

If the foregoing correctly sets forth the understanding between us, please so
indicate in the space provided below for that purpose.

 

 

Very truly yours,

 

 

 

 

ONCONOVA THERAPEUTICS, INC.

 

 

 

 

 

 

 

By:

/s/ Ramesh Kumar, Ph.D

 

 

Name:

Ramesh Kumar, Ph.D

 

 

Title:

President and Chief Executive Officer

 

 

 

 

 

 

 

ACCEPTED as of the date first above written:

 

 

 

 

 

 

 

CANTOR FITZGERALD & CO.

 

 

 

 

 

 

 

By:

/s/ Jeffrey Lumby

 

 

Name:

Jeffrey Lumby

 

 

Title:

Senior Managing Director

 

SIGNATURE PAGE

 

ONCONOVA THERAPEUTICS, INC. – TERMINATION OF SALES AGREEMENT

 

--------------------------------------------------------------------------------